Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Treatment options for hepatobiliary and pancreatic cancer Alberts SR; Gores GJ; Kim GP; Roberts LR; Kendrick ML; Rosen CB; Chari ST; Martenson JAMayo Clin Proc 2007[May]; 82 (5): 628-37Hepatobiliary and pancreatic cancers account for 4% of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers.|*Bile Ducts, Intrahepatic[MESH]|*Liver Transplantation[MESH]|Adenocarcinoma/mortality/surgery/*therapy[MESH]|Antimetabolites, Antineoplastic/therapeutic use[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Bile Duct Neoplasms/diagnosis/*surgery[MESH]|Carcinoma, Hepatocellular/surgery[MESH]|Catheter Ablation[MESH]|Chemoembolization, Therapeutic[MESH]|Cholangiocarcinoma/diagnosis/*surgery[MESH]|Combined Modality Therapy[MESH]|Deoxycytidine/analogs & derivatives/therapeutic use[MESH]|Ethanol/administration & dosage[MESH]|Gemcitabine[MESH]|Hepatectomy[MESH]|Humans[MESH]|Liver Neoplasms/drug therapy/*surgery[MESH]|Pancreatic Neoplasms/mortality/surgery/*therapy[MESH]|Radiation-Sensitizing Agents/therapeutic use[MESH]|Survival Analysis[MESH] |